ENOV
Enovis Corporation
$16.84
Platform & Compounding FCF
50%
Two-stage FCF DCF
Mild
·
Conviction
Overvalued
Trading 0.0% below fair value
Bear
$0.00
-100.0%
5% stage 1 growth, 12% discount
Fair
$0.00
-100.0%
9% stage 1 growth, 12% discount
Bull
$0.00
-100.0%
12% stage 1 growth, 12% discount
Adjust Assumptions
8.9%
12.0%
3.0%
Key Value Driver
FCF growth rate (9% base case)
Terminal Value % of EV
34%
Implied Market Multiple
84.0x
Market is pricing in (growth)
30.4%
vs 8.9% base
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above.
Average Target (15 analysts)
$36.80
Divergence from AlphaVal
100%
Summary
Using a two-stage FCF DCF with 9% growth decelerating over 15 years, discounted at 12%, the base-case intrinsic value is $0.00 per share.
Warnings
Wall Street's average price target is $36.80 (from 15 analysts). Our estimate is 100% below the consensus -- consider that gap carefully.
This stock is 51% below its 52-week high, with weak or declining earnings. That combination often signals real trouble, even though the valuation below is based on other fundamentals.
Key Risks
- P/E alone misleads — earnings depressed by growth investment
- Cyclical or commodity businesses may be misclassified as platforms
- Terminal value dominance suggests sensitivity to long-run assumptions